Stifel Financial’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.1K | Sell |
16,350
-2,656
| -14% | -$6.51K | ﹤0.01% | 3426 |
|
|
2025
Q1 | $127K | Sell |
19,006
-1,457
| -7% | -$9.72K | ﹤0.01% | 3266 |
|
|
2024
Q4 | $257K | Buy |
20,463
+370
| +2% | +$4.65K | ﹤0.01% | 3040 |
|
|
2024
Q3 | $371K | Sell |
20,093
-490
| -2% | -$9.05K | ﹤0.01% | 2847 |
|
|
2024
Q2 | $443K | Buy |
20,583
+537
| +3% | +$11.6K | ﹤0.01% | 2702 |
|
|
2024
Q1 | $540K | Buy |
20,046
+709
| +4% | +$19.1K | ﹤0.01% | 2565 |
|
|
2023
Q4 | $580K | Sell |
19,337
-4,213
| -18% | -$126K | ﹤0.01% | 2481 |
|
|
2023
Q3 | $483K | Buy |
23,550
+2,034
| +9% | +$41.7K | ﹤0.01% | 2509 |
|
|
2023
Q2 | $428K | Buy |
21,516
+2,436
| +13% | +$48.4K | ﹤0.01% | 2609 |
|
|
2023
Q1 | $327K | Buy |
19,080
+2,548
| +15% | +$43.6K | ﹤0.01% | 2754 |
|
|
2022
Q4 | $324K | Buy |
16,532
+2,571
| +18% | +$50.3K | ﹤0.01% | 2704 |
|
|
2022
Q3 | $223K | Buy |
+13,961
| New | +$223K | ﹤0.01% | 2890 |
|